Applied DNA Sciences Inc (APDN)
0.1583
-0.01
(-4.06%)
USD |
NASDAQ |
Nov 21, 16:00
0.156
0.00 (0.00%)
After-Hours: 07:52
Applied DNA Sciences Enterprise Value: -8.969M for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | -8.969M |
| November 20, 2024 | -8.900M |
| November 19, 2024 | -8.892M |
| November 18, 2024 | -8.854M |
| November 15, 2024 | -8.931M |
| November 14, 2024 | -8.810M |
| November 13, 2024 | -8.723M |
| November 12, 2024 | -8.674M |
| November 11, 2024 | -8.681M |
| November 08, 2024 | -8.634M |
| November 07, 2024 | -8.610M |
| November 06, 2024 | -8.743M |
| November 05, 2024 | -8.680M |
| November 04, 2024 | -8.697M |
| November 01, 2024 | -8.578M |
| October 31, 2024 | -8.730M |
| October 30, 2024 | -8.658M |
| October 29, 2024 | -7.334M |
| October 28, 2024 | -7.435M |
| October 25, 2024 | -7.413M |
| October 24, 2024 | -7.407M |
| October 23, 2024 | -7.014M |
| October 22, 2024 | -7.108M |
| October 21, 2024 | -6.737M |
| October 18, 2024 | -7.266M |
| Date | Value |
|---|---|
| October 17, 2024 | -7.335M |
| October 16, 2024 | -7.366M |
| October 15, 2024 | -7.591M |
| October 14, 2024 | -7.510M |
| October 11, 2024 | -7.355M |
| October 10, 2024 | -7.294M |
| October 09, 2024 | -6.995M |
| October 08, 2024 | -6.800M |
| October 07, 2024 | -6.732M |
| October 04, 2024 | -6.794M |
| October 03, 2024 | -6.794M |
| October 02, 2024 | -7.098M |
| October 01, 2024 | -7.056M |
| September 30, 2024 | -3.908M |
| September 27, 2024 | -1.038M |
| September 26, 2024 | -0.1973M |
| September 25, 2024 | 0.0087M |
| September 24, 2024 | -0.7637M |
| September 23, 2024 | 1.039M |
| September 20, 2024 | 2.223M |
| September 19, 2024 | 1.863M |
| September 18, 2024 | 2.996M |
| September 17, 2024 | 3.510M |
| September 16, 2024 | 3.098M |
| September 13, 2024 | 3.510M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-8.969M
Minimum
Nov 21 2024
90.55M
Maximum
Feb 11 2021
17.34M
Average
8.934M
Median
Jan 11 2023
Enterprise Value Benchmarks
| Fonar Corp | 41.17M |
| XWELL Inc | 0.1013M |
| ProPhase Labs Inc | 35.22M |
| Veracyte Inc | 2.744B |
| OncoCyte Corp | 41.59M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 1.880M |
| Revenue (Quarterly) | 0.7975M |
| Total Expenses (Quarterly) | 4.144M |
| EPS Diluted (Quarterly) | 0.47 |
| Gross Profit Margin (Quarterly) | 30.75% |
| Earnings Yield | -7.57K% |
| Normalized Earnings Yield | -10658.74 |